Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07345676 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening Outreach
A NA study, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT07345676: Recruiting NA study, sponsored by Yale University.
NCT07345676 is a NA study that is actively recruiting participants, run by Yale University. The registered enrollment target is 2,000 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07345676, a NA study, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
This is a 4 arm pragmatic trial to test a multicomponent intervention designed to improve adherence to colorectal cancer screening.
Primary Outcome
Number of participants who completed or scheduled screening (colonoscopy or stool-based test) within 3 months of randomization.
Interventions
- BEHAVIORAL Bundled messaging intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT07345676 shows while recruiting
NCT07345676 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 1 intervention - of which Bundled messaging intervention is the first listed.
NCT07345676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07345676 about?
NCT07345676 is a clinical study titled "Colorectal Cancer Screening Outreach". This is a 4 arm pragmatic trial to test a multicomponent intervention designed to improve adherence to colorectal cancer screening.
What is the current status of trial NCT07345676?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2026-06-23. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07345676?
The interventions under investigation include: Bundled messaging intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07345676?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07345676's enrollment target sits among peer trials
2,000 52nd of 2000 higher than 1,947 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI